Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Physician-assisted doping of athletes has transformed high-performance sport into a chronically overmedicated subculture and spread so-called hormonal rejuvenation to the general public.
Medical specialty boards improve the quality and safety of health care, but they can overreach, and their board members express disapproval of board action by petition and through legal action.
AMA J Ethics. 2015;17(3):193-198. doi:
10.1001/journalofethics.2015.17.3.spec1-1503.